The United States boasts a robust pharmaceutical industry, particularly when it comes to the production of active pharmaceutical ingredients (APIs). Among these APIs, tirzepatide has gained significant recognition due to its potential in treating type 2 diabetes and other metabolic disorders. Many companies have emerged as key manufacturers of tirz

A Contract Development and Manufacturing Organization (CDMO) specializing in GMP peptides delivers a comprehensive suite of capabilities to support the development and production of pharmaceutical peptides. These organizations deploy state-of-the-art facilities and skilled personnel to ensure compliance with stringent regulatory requirements, such